Randomized, Double-Blind, Placebo-Controlled Studies to Evaluate Treatment with Aducanumab (BIIB037) in Patients with Early Alzheimer's Disease: Phase 3 Study Design

Vissia Viglietta, John O'Gorman, Leslie Williams, Ying Tian, Alfred Sandrock, Rachelle Doody, Stephen Salloway, Frederik Barkhof, Bruno Vellas, Mary Sano, Paul Aisen, Jeffrey Sevigny

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalNeurology
Volume86
Publication statusPublished - 5 Apr 2016

Cite this